J&J Settles Latest Risperdal Case Before Trial

Law360, Philadelphia (January 6, 2017, 5:23 PM EST) -- Ahead of a trial that was scheduled to get underway in Philadelphia beginning on Monday, a Johnson & Johnson unit has agreed to settle a lawsuit alleging that a New York boy grew female breasts after being treated with the antipsychotic drug Risperdal.

The settlement comes as Janssen Pharmaceuticals Inc. was gearing up to face what would have been the seventh trial over breast growth allegedly linked to the powerful antipsychotic since juries began hearing cases over the drug in earnest two years ago.

“We resolved this case and the terms of the settlement are confidential,” Janssen spokeswoman Jessica Castles Smith...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS